A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.
As the world continues to confront severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV) is also causing severe respiratory illness in millions of infants, elderly individuals, and...
Read More